Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients
News
By David Pinato et al. published in Cancer Discovery. A large Imperial-led study has revealed valuable insights into the impact and risk factors for cancer patients with COVID-19. The findings, from almost 900 cancer patients diagnosed with SARS-CoV-2 infection in the UK, Spain, Italy and Germany, highlight a number of...
COSMIC-19, COVID-19 and cancer research at Manchester
News
Below are two examples of work being done in Manchester to support the COVID effort. COSMIC-19: COntinuous Signs Monitoring In COVID-19 patients open in Manchester The Christie-sponsored study COSMIC-19 (COntinuous Signs Monitoring In Covid-19 patients), led by Prof Fiona Thistlethwaite is open to recruitment at The Christie and Manchester University...
ECMC North Conference: The impact of COVID-19 on early phase cancer trials and the approaches taken to adapt to the pandemic to ensure patient safety
Event
Wondering what other centres do to overcome the challenges of COVID-19 for early phase trials? Interested in contributing to sharing best practice? Don’t know who to ask about COVID-19 implications when planning future trials? Then join ECMC North in the educational event to help develop a framework for delivery during...
Delivering early phase cancer trials during COVID-19 pandemic and development of ECMC COVID-19 Community Hub - online launch event on 19 October
News
Wondering what other centres do to overcome the challenges of COVID-19 for early phase trials? Interested in contributing to sharing best practice? Don’t know who to ask about COVID-19 implications when planning future trials? Then join ECMC North in the educational event to help develop a framework for delivery during...
Delivering early phase cancer trials during COVID-19 pandemic and development of ECMC COVID-19 Community Hub - online launch event
News
The teams from ECMC North successfullly delivered their first online educational event on 19 October 2020. We have now moved to developing the content for the ECMC COVID-19 Community Hub, a curated online platform to build on the learnings from the workshops held in October.
Spotlight interview - Ben Hood, Research Nurse
News
We caught up with Ben Hood, CRUK Senior Research Nurse at Newcastle ECMC, to hear about his recent win at the RCNi Nurse Awards and all the amazing work he has been doing in Newcastle. He talks about the impact of COVID-19 on his role and the work being done to ensure patients are still able to take part in early phase trials.
Lessons learned: Delivering early phase cancer trials during the COVID-19 pandemic
News
The teams from ECMC North delivered successfully their first on-line educational event on October 19th 2020. We have now moved to developing the content for the ECMC COVID-19 Community Hub, a curated on-line platform to build on the learnings from the workshops held in October.
Giving the immune system a double boost against cancer
News
Researchers from the University of Cambridge and Cold Spring Harbour Laboratory (CSHL) have completed an early phase clinical trial of a drug called plerixafor showing that it induces an integrated immune response in the tumours of patients with cancer types that do not usually respond to immunotherapy.
University spinout to develop new cancer drug
News
Researchers in the University of Sheffield Department of Oncology and Metabolism have formed a new university spinout company (Modulus Oncology) with experienced drug development entrepreneurs Dr Clare Wareing and Dr Alan Wise from Edinburgh-based bioincubator company Cumulus Oncology.
The Trials Acceleration Programme (TAP)
News
Two trials from the Trials Acceleration Programme (TAP) will be opening across the UK - VICTOR and PROMise